Novel 1,2,4-Thiadiazole Derivatives as Potent Neuroprotectors: Approach to Creation of Bioavailable Drugs
- 6 March 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 9 (8), 2156-2167
- https://doi.org/10.1021/mp300011r
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Novel purine-based fluoroaryl-1,2,3-triazoles as neuroprotecting agents: Synthesis, neuronal cell culture investigations, and CDK5 docking studiesBioorganic & Medicinal Chemistry Letters, 2011
- Novel 1,2,4-thiadiazoles with an NO-producing fragmentDoklady Chemistry, 2010
- Synthesis and anticonvulsant activity of some substituted 1,2,4-thiadiazolesEuropean Journal of Medicinal Chemistry, 2009
- Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyondNature Reviews Drug Discovery, 2006
- Ligands for Glutamate Receptors: Design and Therapeutic ProspectsJournal of Medicinal Chemistry, 2000
- Neuropharmacology of AMPA and kainate receptorsNeuropharmacology, 1998
- Glutamate in CNS disorders as a target for drug development: an updateDrug News & Perspectives, 1998
- Calcium Hypothesis of Alzheimer's Disease and Brain AgingaAnnals of the New York Academy of Sciences, 1994
- Molecular Diversity of Glutamate Receptors and Implications for Brain FunctionScience, 1992
- beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicityJournal of Neuroscience, 1992